Year :
2024
| Month :
June
| Volume :
18
| Issue :
6
| Page :
QR01 - QR04
Full Version
Pregnancy Outcomes among Antenatal Women with Sickle Cell Anaemia: A Case Series
Published: June 1, 2024 | DOI: https://doi.org/10.7860/JCDR/2024/68474.19513
RDN Swetha, Srujana Palavalasa, Jhansi Rani Kathari, Rosemary Penumaka
1. Assistant Professor, Department of Obstetrics and Gynaecology, Andhra Medical College, Visakhapatnam, Andhra Pradesh, India.
2. Assistant Professor, Department of Obstetrics and Gynaecology, Andhra Medical College, Visakhapatnam, Andhra Pradesh, India.
3. Assistant Professor, Department of Obstetrics and Gynaecology, Andhra Medical College, Visakhapatnam, Andhra Pradesh, India.
4. Assistant Professor, Department of Obstetrics and Gynaecology, Andhra Medical College, Visakhapatnam, Andhra Pradesh, India.
Correspondence Address :
Dr. Rosemary Penumaka,
9-14-1, Aarthika Empire, Flat 202, VIP Road, CBM Compound, Visakhapatnam-530003, Andhra Pradesh, India.
E-mail: dr.rosemarypenumaka@gmail.com
Abstract 
Sickle Cell Anaemia (SCA) is a common and severe form of an inherited blood disorder known as Sickle Cell Disease (SCD). SCD is a group of autosomal recessive disorders characterised by point mutation resulting in the formation of structurally defective Haemoglobin (Hb), called Haemoglobin S (HbS). SCD is clinically heterogeneous, with variability in manifestation ranging from being asymptomatic to a severe crisis that can be fatal. Pregnancies complicated by SCA are high-risk due to the disease’s heterogeneous manifestations and propensity for maternal and foetal complications. This case series aimed to understand associated maternal and foetal outcomes at a tertiary care hospital. Women presented with a spectrum of clinical presentations from uncomplicated deliveries to cases involving severe acute and chronic sequelae. Preterm birth before 37 weeks, low birth weight, and Neonatal Intensive Care Unit (NICU) admissions were common, reflecting known risks of growth restriction and prematurity. Previous adverse outcomes such as stillbirth and spontaneous abortion highlighted the threat to maternal and perinatal mortality. Acute sickle cell crises and splenic sequestration occurred. Advanced maternal age and comorbidities such as asthma exacerbated the disease burden. Most of the participants suffered from recurrent adverse outcomes with subsequent gestations. As most of the participants belonged to backward communities, targeted screening could help with earlier identification and counselling to reduce disease incidence in vulnerable populations.
Keywords
Haematologic pregnancy complications, Low birth weight infant, Neonatal intensive care, Premature births
Introduction
Sickle Cell Anaemia (SCA) is a common and severe form of an inherited blood disorder known as Sickle Cell Disease (SCD). SCD is a group of autosomal recessive disorders characterised by point mutations, resulting in the formation of structurally defective Haemoglobin (Hb), called Haemoglobin S (HbS). SCD is clinically heterogeneous, with variability in manifestation, ranging from being asymptomatic to a severe crisis that can be fatal (1),(2). It is a disease of tremendous clinical variability to the extent that clinical presentation is seldom similar between any two individuals (2),(3).
Over 300,000 babies are born with SCD annually. Approximately 90% of these births take place in Low and Middle-income Countries (LMICs). The total number of births of babies with SCD has increased globally by 13.7% (4),(5).
While SCA arises from the same genetic mutation in all those affected, there is significant variability in its clinical manifestations between individuals (6). Common presentations include vaso-occlusive crises, acute chest syndrome, and haemolytic anaemia, though the frequency, severity, and specific symptoms experienced differ greatly (7). Some experience mild disease, while others suffer from severe, life-threatening complications regularly.
This heterogeneity is also apparent in pregnancies complicated by SCA (8). Studies have shown elevated risk of maternal complications, such as anaemia, infection, preeclampsia and foetal growth restriction in affected mothers (9),(10). Their infants also have higher odds of low birth weight, preterm birth and respiratory issues (11).
The present case series aimed to address the maternal and foetal outcomes among SCA affected pregnant women over two years.
Case Report
The case series included eight patients presenting with SCA. According to the World Health Organisation (WHO), anaemia is defined as a Hb concentration of less than 12.0 g/dL (12). As part of the hospital’s standard treatment protocol, all the women were subjected to haemogram and peripheral smear. Women found to be sickling positive were tested by Hb electrophoresis to confirm the diagnosis of sickle cell homozygous state or trait.
All cases were studied for demographic parameters (age, locality), booking status in current pregnancy and Period of Gestation (POG). All the relevant laboratory parameters, including haemogram and Hb electrophoresis, Liver Function Tests (LFT), and Ultrasonography (USG) of the abdomen were assessed. All complications during the antenatal, intranatal and postnatal periods were noted. Parameters related to SCD, like the occurrence of sickle crisis (flow of blood is blocked to an area because of the sickled cells) (13), need for hospitalisation, prophylactic blood transfusions, total requirement of blood and its components in the antenatal, intranatal and postnatal periods were noted. Maternal outcomes, such as duration of pregnancy, mode of delivery, details regarding any abnormality during pregnancy, and abnormal course in the labour were noted. Neonatal outcomes, such as birth weight, and Neonatal Intensive Care Unit (NICU) admission/premature baby unit admission were noted.
Case 1
A 21-year-old multigravida (G2P1L1), from a tribal area was admitted with Hb of 3 g/dL at 39 weeks of gestation (Table/Fig 1). She was unbooked. Her previous pregnancy was normal vaginal full-term delivery and the baby is alive and healthy. She had associated pre-eclampsia. She had a history of jaundice and joint pains on and off since childhood. During pregnancy, she had cough, expectoration, haemoptysis, and chest pain since the 8th month (chest crisis). Her investigations revealed normocytic hypochromic anaemia, moderate neutrophilia, and leucocytosis with sickling. Hb electrophoresis revealed sickle cell trait. On abdominal USG, she had a fatty liver, normal spleen and hepatomegaly. Her LFT was normal (Table/Fig 2).
In the present pregnancy, she had a normal vaginal delivery. She was transfused with five units of blood and was given three iron injections as soon as she was diagnosed as being anaemic. Her Hb at discharge was 8.6 g/dL (Table/Fig 3). The birth weight was 2.5 kg (Table/Fig 4). The baby was admitted to the NICU for meconium-stained liquor.
Case 2
A 30-year-old multigravida G2P1L1 from an urban area was admitted at 36 weeks of gestation. The first pregnancy was a twin pregnancy and intrauterine death occurred at 7th month (Table/Fig 1). During the second pregnancy, she had jaundice and was diagnosed with SCA in the 8th month. The child had foetal distress and was delivered at full term by emergency Lower Segment Caesarean Section (LSCS) (Table/Fig 2). The child is alive and healthy. There was a history of malaria in the 8th month (Table/Fig 5). During the present pregnancy, she had a joint crisis and right hip joint pain. Her investigations had revealed normocytic hypochromic anaemia and neutrophilia with sickling. Her LFT was elevated. On USG, she had cholelithiasis and an absent spleen. Her Hb at admission was 10 g/dL. She was transfused one unit of blood. Her Hb at discharge was 9 g/dL (Table/Fig 3). The third (current) pregnancy was full-term. Elective LSCS was done for post C-section and Intrauterine Growth Restriction (IUGR) in the current pregnancy. The child is alive and healthy. The birth weight was 2.4 kg. Appearance, Pulse, Grimace, Activity, Respiration (APGAR) score was 6-8-10 (Table/Fig 4). The baby was admitted to the NICU for IUGR.
Case 3
A 28-year-old multigravida (G3P2L1D1) from a tribal area was admitted at 36 weeks of gestation (Table/Fig 1). The first pregnancy ended in intrauterine death in the 8th month. There was a history of malaria and jaundice during the first pregnancy at the 8th month. She also had a history of gestational hypertension. The second pregnancy was a full-term, normal vaginal delivery. The child is alive and healthy. The mother was diagnosed with SCA during her third (current) pregnancy. Her investigations had revealed normocytic hypochromic anaemia and neutroleucocytosis with sickling. On Hb electrophoresis, she had an HbSS homozygous trait (Table/Fig 2). Her LFT was elevated. Her USG had revealed hepatomegaly, cholelithiasis and absent spleen. Her Hb at admission was 7 g/dL. She was transfused two units of blood. Her Hb at discharge was 8 g/dL (Table/Fig 3). The third (current) pregnancy was a full-term, normal vaginal delivery. The child is alive and healthy. The birth weight was 2.5 kg. APGAR score was 6-8-10. The baby was admitted to the NICU for meconium-stained liquor (Table/Fig 4).
Case 4
A 22-year-old multigravida (G2P1L1) from an urban area was admitted at 38 weeks of gestation (Table/Fig 1). The first pregnancy ended in neonatal death. She had a history of jaundice and chest crisis during the 8th month diagnosis. She also had a history of gestational hypertension. Her investigations revealed normocytic hypochromic anaemia, neutrophilic leucocytosis, and increased nucleated Red Blood Cells (RBCs) with sickling. On Hb electrophoresis, she had an HbSS homozygous trait (Table/Fig 2). Her LFT was elevated. Her USG had revealed hepatomegaly, ascites, cholelithiasis, left lower lobe consolidation and absent spleen. Her Hb at admission was 8 g/dL. She was transfused three units of blood. Her Hb at discharge was 8.3 g/dL (Table/Fig 3). The second pregnancy (current) was full-term. Emergency LSCS was done for post-LSCS. The child is alive and healthy. The birth weight was 2.9 kg. APGAR score was 8-10 (Table/Fig 4).
Case 5
A 28-year-old multigravida (G2A1) from a tribal area was admitted at 39 weeks of gestation (Table/Fig 1). The first pregnancy ended in spontaneous abortion at 3rd month. She had a history of recurrent joint pains for 13 years. Her investigations had revealed normocytic hypochromic anaemia and neutrophilia with sickling. On Hb electrophoresis, she had an HbSS homozygous trait (Table/Fig 2). Her LFT was elevated. Her USG had revealed cholelithiasis and an absent spleen. Her Hb at admission was 9 g/dL. She was transfused one unit of blood (Table/Fig 3). Her Hb at discharge was 9.2 g/dL. The second (current) pregnancy was precious. Emergency LSCS was done at full-term for premature rupture of membranes (for 10 hours), meconium-stained liquor and foetal distress. The child was alive and healthy. The birth weight was 3.3 kg. APGAR score was 8-10 (Table/Fig 4). The baby was admitted to the NICU.
Case 6
A 20-year-old primigravida from an urban area was admitted at 38 weeks of gestation (Table/Fig 1). She had a history of malaria and pre-eclampsia. Her investigations had revealed normocytic hypochromic anaemia and neutrophilia with sickling. On Hb electrophoresis, she had an HbSS homozygous trait (Table/Fig 2). Her LFT was elevated. Her USG had revealed cholelithiasis and an absent spleen. Her Hb at admission was 8 g/dL. She was transfused one unit of blood (Table/Fig 3). Her Hb at discharge was 8.2 g/dL. The first (current) pregnancy resulted in full-term, normal vaginal delivery. The child is alive and healthy. The birth weight was 3 kg. APGAR score was 8-10 (Table/Fig 4).
Case 7
A 25-year-old multigravida (G2A1) from an urban area was admitted at 39 weeks of gestation (Table/Fig 1). She had a history of Tuberculous Meningitis (TBM) and right hemiparesis at 18 years of age. The first pregnancy ended in spontaneous abortion at 2nd month. Her investigations had revealed microcytic hypochromic anaemia with sickling. On Hb electrophoresis, she had sickle cell trait (Table/Fig 2). Her LFT was normal. Her USG had revealed cholelithiasis and a normal spleen. Her Hb at admission was 8 g/dL. She was transfused one unit of blood (Table/Fig 3). Her Hb at discharge was 8 g/dL. The second (current) pregnancy was delivered at full-term by normal vaginal delivery. The child is alive and healthy. The birth weight was 3.5 kg. APGAR score was 8-10 (Table/Fig 4).
Case 8
A 28-year-old multigravida G2L1 G2P4L1D3 from a tribal area was admitted at 32 weeks of gestation (Table/Fig 1). She had a history of childhood asthma, tonsillectomy, and pre-eclampsia. She had undergone cholecystectomy for gallstones at 15 years of age. The first pregnancy ended in full-term stillbirth. There was a history of jaundice since 2nd month of first pregnancy. The baby had pathological jaundice. The second pregnancy was at full-term by normal vaginal delivery. But the baby died at 4th month due to jaundice. The third pregnancy ended in full-term stillbirth due to jaundice. The mother was diagnosed with SCA during the fourth pregnancy in the 8th month. It was full term, normal vaginal delivery with cerebral palsy child. Her investigations had revealed microcytic hypochromic anaemia with sickling. On Hb electrophoresis, she had HbSS homozygous trait (Table/Fig 2). Her LFT was elevated. She had prolonged Prothrombin Time (PT), International Normalised Ratio (INR), and Activated Partial Thromboplastin Time (APTT). Her USG had revealed hepatomegaly and an absent spleen. The fifth (current) pregnancy was preterm, elective LSCS. It was done due to bad obstetric history. The child is alive and healthy. The birth weight was 2.3 kg. APGAR score was 6-8-10 (Table/Fig 4). The baby was admitted to NICU for jaundice and preterm delivery.
The overall clinical presentation and treatment of all the cases are presented in (Table/Fig 5).
Discussion
There has long been recognition that SCA manifests with significant clinical variability, both between patients and within the course of an individual’s disease. However, the underlying basis for this heterogeneity is still under investigation (14). A better understanding of what drives differences in SCA severity and complications could have important implications for improving risk stratification and personalised treatment approaches.
The pathogenesis of SCA stems from a single point mutation in the β-globin gene that results in the production of abnormal HbS (15). Under conditions of low oxygen tension, HbS polymerises within RBCs, distorting their morphology into a rigid sickle shape. This sickling phenomenon drives the primary vascular occlusive events and downstream sequelae that underlie the multi-systemic manifestations of SCA (16). The core pathogenic process of SCA causes impaired microcirculation. This occurs due to abnormal polymerisation of Hb within RBCs under hypoxic conditions, causing their distortion into rigid sickle shapes that obstruct blood flow (17).
Acute sickle cell-related complications were documented, including chest crisis, jaundice episodes, and gallbladder disease requiring surgery. The women also exhibited chronic organ damage, including splenic sequestration and hepatic dysfunction. Prior comorbid conditions, such as asthma and Tuberculosis (TB) further increased vulnerability. Together, these findings exemplify the multisystem involvement and clinical heterogeneity encompassed under the umbrella diagnosis of SCA.
This case series was done to understand both maternal and foetal outcomes associated with SCA-affected pregnancies receiving care. Existing literature primarily reported isolated case studies without a broader examination of trends (18),(19).
A retrospective study done by Khalid N et al., examined the pregnancy outcomes among 28 women with SCD or trait. The high rates of pre-eclampsia, preterm labour, IUGR and oligohydramnios were found to be similar to the authors’ findings. Regarding SCD manifestations, anaemia requiring transfusion and infections were also common, as was the need for blood management. Their mode of delivery and perinatal outcomes also reflected the authors’ observations of increased operative vaginal and Caesarean rates driven by foetal distress, alongside NICU admissions and morbidity (20).
Although the case series had a smaller sample size, it could have subject selection bias. Larger multicentre studies employing standardised disease severity classification tools and detailed recording of comorbidities, socioeconomic factors, and other confounding variables are needed to better understand the natural history and outcomes of SCA.
Conclusion
The present case series has identified increased morbidity in pregnant women with SCD and a few with sickle cell trait. The common maternal complications were anaemia and organ involvement, while prematurity and low birth weight was frequent neonatal issues. There is a need for public health measures to proactively screen those belonging to high-risk communities. Such screening could help raise awareness and allow counselling to help reduce the incidence of SCD among newborns from these vulnerable populations.
Reference
|
| | 1. | Sedrak A, Kondamudi NP. Sickle Cell Disease. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Feb 3]. Available from: http:// www.ncbi.nlm.nih.gov/books/NBK482384/.
| | 2. | Chakravorty S, Williams TN. Sickle cell disease: A neglected chronic disease of increasing global health importance. Arch Dis Child. 2015;100(1):48-53.
[ CrossRef] [ PubMed] | | 3. | Edwards CL, Scales MT, Loughlin C, Bennett GG, Harris-Peterson S, De Castro LM, et al. A brief review of the pathophysiology, associated pain, and psychosocial issues in sickle cell disease. Int J Behav Med. 2005;12(3):171-79.
[ CrossRef] [ PubMed] | | 4. | Thomson AM, McHugh TA, Oron AP, Teply C, Lonberg N, Vilchis Tella V, et al. Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000-2021: A systematic analysis from the Global Burden of Disease Study 2021. Lancet Haematol. 2023;10(8):e585-99.
| | 5. | Dua M, Bello-Manga H, Carroll YM, Galadanci AA, Ibrahim UA, King AA, et al. Strategies to increase access to basic sickle cell disease care in low- and middle-income countries. Expert Rev Hematol. 2022;15(4):333-44.
[ CrossRef] [ PubMed] | | 6. | Serjeant GR. The natural history of sickle cell disease. Cold Spring Harb Perspect Med. 2013;3(10):a011783.
[ CrossRef] [ PubMed] | | 7. | Ochocinski D, Dalal M, Black LV, Carr S, Lew J, Sullivan K, et al. Life-threatening infectious complications in sickle cell disease: A concise narrative review. Front Pediatr. 2020;8:38.
[ CrossRef] [ PubMed] | | 8. | Inusa BPD, Hsu LL, Kohli N, Patel A, Ominu-Evbota K, Anie KA, et al. Sickle Cell Disease-Genetics, Pathophysiology, Clinical Presentation and Treatment. Int J Neonatal Screen. 2019;5(2):20.
[ CrossRef] [ PubMed] | | 9. | Slawek-Szmyt S, Kawka-Paciorkowska K, Cieplucha A, Lesiak M, Ropacka- Lesiak M. Preeclampsia and fetal growth restriction as risk factors of future maternal cardiovascular disease-a review. J Clin Med. 2022;11(20):6048.
[ CrossRef] [ PubMed] | | 10. | Abu-Ouf NM, Jan MM. The impact of maternal iron deficiency and iron deficiency anemia on child’s health. Saudi Med J. 2015;36(2):146-49.
[ CrossRef] [ PubMed] | | 11. | Smith-Whitley K. Complications in pregnant women with sickle cell disease. Hematol Am Soc Hematol Educ Program. 2019;2019(1):359-66.
[ CrossRef] [ PubMed] | | 12. | Cappellini MD, Motta I. Anemia in clinical practice-definition and classification: Does hemoglobin change with aging? Semin Hematol. 2015;52(4):261-69.
[ CrossRef] [ PubMed] | | 13. | Hiran S. Multiorgan dysfunction syndrome in sickle cell disease. J Assoc Physicians India. 2005;53:19-22.
| | 14. | Williams TN, Thein SL. Sickle cell anemia and its phenotypes. Annu Rev Genomics Hum Genet. 2018;19:113-47.
[ CrossRef] [ PubMed] | | 15. | Ashorobi D, Ramsey A, Yarrarapu SNS, Bhatt R. Sickle Cell Trait. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Feb 3]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK537130/.
| | 16. | Nader E, Romana M, Connes P. The red blood cell-inflammation vicious circle in sickle cell disease. Front Immunol. 2020;11:454.
[ CrossRef] [ PubMed] | | 17. | Connes P, Alexy T, Detterich J, Romana M, Hardy-Dessources MD, Ballas SK. The role of blood rheology in sickle cell disease. Blood Rev. 2016;30(2):111-18.
[ CrossRef] [ PubMed] | | 18. | Kar K, Samantaroy S, Panda J, Jena P. Sickle cell anemia complicating pregnancy in coronavirus disease era: Managing two maladies. J South Asian Fed Obstet Gynaecol. 2021;13(6):441-42.
[ CrossRef] | | 19. | Anand PK, Mohanty SS, Toteja GS, Purohit A, Babu BV. Clinical features in paediatric sickle cell anaemia cases from Rajasthan, India: A case series. Indian J Hematol Blood Transfus [Internet]. 2024 [cited 2024 Mar 13]. Available from: https://doi.org/10.1007/s12288-023-01728-0.
[ CrossRef] [ PubMed] | | 20. | Khalid N, Divya S, Ravi RS, Amarpali KS. Study on the feto-maternal outcome in sickle cell hemoglobinopathy at a rural tertiary care center in Kerala. J Popul Ther Clin Pharmacol. 2023;30(18):2570-76. |
DOI: 10.7860/JCDR/2024/68474.19513
Date of Submission: Nov 10, 2023
Date of Peer Review: Jan 10, 2024
Date of Acceptance: Apr 25, 2024
Date of Publishing: Jun 01, 2024
AUTHOR DECLARATION:
• Financial or Other Competing Interests: None
• Was informed consent obtained from the subjects involved in the study? Yes
• For any images presented appropriate consent has been obtained from the subjects. NA
PLAGIARISM CHECKING METHODS:
• Plagiarism X-checker: Nov 15, 2023
• Manual Googling: Jan 18, 2024
• iThenticate Software: Apr 23, 2024 (5%)
AUTHOR DECLARATION: Author Origin
EMENDATIONS: 6
|